HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice.

AbstractAIMS:
The aim of the study was to isolate human bifidobacteria that inhibit growth of Salmonella typhimurium in vitro, and provide protection against Salmonella infection in mice.
METHODS AND RESULTS:
A total of 92 micro-organisms, which displayed antagonist activity against Salm. typhimurium in vitro, were isolated from human faecal material. Based on their Gram stain status, cultures were pooled and tested for anti-Salmonella activity. The Gram-variable group was the most active. From that group, three bifidobacteria (Laftitrade markB22, B74 and B97) individually showed good pathogen inhibition in vivo.
CONCLUSION:
Oral administration of certain human bifidobacteria provides protection against Salmonella infection in mice.
SIGNIFICANCE AND IMPACT OF THE STUDY:
These results indicate that certain bifidobacteria may be used as a prophylaxis for reduced incidence and severity of Salmonella infections.
AuthorsA Henriksson, P L Conway
JournalJournal of applied microbiology (J Appl Microbiol) Vol. 90 Issue 2 Pg. 223-8 (Feb 2001) ISSN: 1364-5072 [Print] England
PMID11168725 (Publication Type: Journal Article)
Topics
  • Animals
  • Antibiosis
  • Bifidobacterium (growth & development, isolation & purification)
  • Feces (microbiology)
  • Female
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Salmonella Infections (microbiology, prevention & control)
  • Salmonella typhimurium (growth & development)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: